Wallenstam interim report 1 January – 30 September 2015

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Nov 3, 2015 at 2:15 AM

CFO Susann Linde, in charge of IR, comments on the interim report at www.wallenstam.se/presentationer. A conference call with Susann Linde will take place at 09.30 a.m (CET) at www.financialhearings.com, the presentation is available at www.wallenstam.se/presentationer. 1 JANUARY–30 SEPTEMBER 2015 • Income from property management amounted to SEK 512 million (464), an increase of 10 percent. • Properties were sold with a value of SEK 1,850 million (1,280). This resulted in realized changes in value of SEK 144 million (152), which is 9 percent over the latest valuation. • Unrealized changes in the value of investment properties amounted to SEK 1,880 million (498), of which new construction represented SEK 435 million (85). • Changes in the value of derivative instruments amounted to SEK 30 million ( -595). • Profit after tax amounted to SEK 2,167 million (187), equivalent to SEK 6.5 (0.6) per share. • Rental income for the interim period amounted to SEK 1,159 million (1,186). • Acquisitions and investments in properties totalled SEK 2,561 million (1,328). • The growth rate in net asset value, excluding dividends and repurchases, on a rolling full-year basis was 17.7 percent. • During the period, construction started on approximately 370 apartments. We had around 1,300 apartments under construction on the closing day. 1 JULY–30 SEPTEMBER 2015 • Income from property management amounted to SEK 190 million (173). • Unrealized changes in the value of investment properties amounted to SEK 169 million (105), of which new construction represented SEK 133 million (17). • Changes in the value of derivative instruments amounted to SEK -130 million ( -168). • Profit after tax amounted to SEK 185 million (-167), equivalent to SEK 0.6 ( -0.5) per share. • Rental income for the third quarter amounted to SEK 387 million (393). Comment from Hans Wallenstam, CEO “We are generating considerable surplus value through our work on building apartments. We are also creating value through conversions and effective management. Almost 80 percent of the increase in value during the quarter came from our new construction projects.” “Happily, we reported net asset value growth on a rolling full-year basis of 17.7 percent during the period, a fantastic performance that is above our goal of an average net asset value growth of 10 percent per year.” “The result shows that the operations are continuing to perform very strongly. Income from property management during the period amounted to SEK 512 million, an increase of 10 percent. We have a strong financial position with a low loan -to-value ratio of 44 percent, and a high equity/assets ratio of 43 percent. We feel very satisfied with the result and performance to date!” For the complete report, please refer to the attached PDF. Wallenstam is required to make the information in this report public under the provisions of the Swedish Financial Markets Act and the Swedish Financial Instruments Trading Act. The information was made publicly available on November 3, 2015 at 8:00 a.m. (CET). For further information: Susann Linde, CFO and IR Director Wallenstam AB (publ) tel. 46 31-20 00 00 or 46 0705-17 11 34 Elisabeth Vansvik, Director of Communications Wallenstam AB (publ) tel. 46 31-20 00 00 or 46 705-17 11 38 www.wallenstam.se Wallenstam is a growing property company that manages, builds and develops properties for sustainable living and enterprise in Gothenburg and Stockholm. The property holding is valued at around SEK 30 billion and the customer base consists of just over 7,300 households and 1,000 enterprises. The total lettable area is around 1 million sq m. Wallenstam is self-sufficient in renewable energy through the company Svensk NaturEnergi and its 67 wind turbines and hydroelectric plants in operation. The company’s B shares have been listed on Nasdaq Stockholm since 1984.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...